Now more than ever, it is critical that anyone contemplating investment in a healthcare sector carefully review the target company’s compliance protocols. We have always strongly recommended that investors analyze the company’s compliance program, as well as efforts at adhering to

Continue Reading Compliance Plans Under the PPACA: One More Reason for Careful Compliance Program Analysis

The Patient Protection and Affordable Healthcare Act (commonly known as the "healthcare reform" bill) includes significant new transparency and disclosure obligations that apply to physicians, hospitals, and medical device and pharmaceutical manufacturers. 

Some of these transparency and disclosure obligations are

Continue Reading Transparency Initiatives in Health Reform Bring Burdens and Opportunities

Yesterday, the House voted in two separate votes to approve healthcare reform legislation. In a vote of 219-212, the House approved the healthcare reform bill that was passed by the Senate on Christmas Eve. Then, in a vote of 220-211, the House approved

Continue Reading Healthcare Reform Update: U.S. House Votes to Approve Senate Bill and Reconciliation Bill